Elucidation of the relation between multi-ligand receptor, FEEL and diseases

阐明多配体受体、FEEL与疾病之间的关系

基本信息

  • 批准号:
    16390027
  • 负责人:
  • 金额:
    $ 4.29万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Multiligand receptors (scavenger receptors) are defined as its ability to recognize several structurally and functionally dissimilar molecule such as modified lipoproteins, advanced glycation end-products (AGE) and apoptotic cells. It is suggested that they were implicated in various diseases such as arteriosclerosis and diabetes. Employing expression cloning, we have cloned a multiligand receptor termed FEEL-1 (fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor-1) expressed in human endothelial cells and subsequently cloned FEEL-2 by data base search. The receptors had binding activities to modified lipoproteins, cells of both Gram-positive, Gram-negative bacteria and AGE. Soluble form of human FEEL-1 was expressed using adenoviral vector, and the binding activities of soluble form of FEEL-1 to acetyl-LDL or AGE were determined. Expression of miRNA (micro RNA) against FEEL employing fiber mutant adenoviral vector in murine liver sinusoidal endothelial cells suggested that both FEEL-1 and FEEL-2 contribute to the hepatic reticuloendothelial system in clearance of waste materials from blood flow. Knockout mice of FEEL-1 or FEEL-2 were generated by gene targeting. Determination of the physiological function of FEEL will provide a new insight into the pathological function of this multiligand receptor.
多配体受体(scavenger receptor)被定义为识别多种结构和功能不同的分子的能力,如修饰的脂蛋白、晚期糖基化终产物(AGE)和凋亡细胞。这表明,他们牵连在各种疾病,如动脉硬化和糖尿病。采用表达克隆,我们已经克隆了一个多配体受体FEEL-1(fasciclin,EGF样,层粘连蛋白型EGF样和链接域含有清道夫受体-1)在人内皮细胞中表达,随后克隆FEEL-2的数据库搜索。这些受体对修饰的脂蛋白、革兰氏阳性菌、革兰氏阴性菌细胞和AGE均有结合活性。使用腺病毒载体表达可溶形式的人FEEL-1,并测定可溶形式的FEEL-1与乙酰-LDL或AGE的结合活性。使用纤维突变腺病毒载体在鼠肝窦内皮细胞中表达针对FEEL的miRNA(microRNA)表明FEEL-1和FEEL-2都有助于肝网状内皮系统从血流中清除废物。通过基因打靶产生FEEL-1或FEEL-2的敲除小鼠。FEEL的生理功能的测定将为这种多配体受体的病理功能提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADACHI Hideki其他文献

ADACHI Hideki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADACHI Hideki', 18)}}的其他基金

Analysis for physical roles of scavenger receptor FEEL
清道夫受体FEEL的物理作用分析
  • 批准号:
    21590084
  • 财政年份:
    2009
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Structure and function of ligands for novel oxidized-LDL receptors in endothelial cell
内皮细胞中新型氧化LDL受体配体的结构和功能
  • 批准号:
    13672317
  • 财政年份:
    2001
  • 资助金额:
    $ 4.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Leveraging pleiotropy to develop polygenic risk scores for cardiometabolic diseases
利用多效性开发心脏代谢疾病的多基因风险评分
  • 批准号:
    10797389
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Household Air Pollution, Adiposity, and Cardiorenal Disease Risk in Children
家庭空气污染、肥胖和儿童心肾疾病风险
  • 批准号:
    10739062
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Targeting the hepatic adropin signaling pathway in obesity
靶向肥胖中的肝脏 adropin 信号通路
  • 批准号:
    10677279
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Somos Esenciales: Community Revitalization and Health through Latino Arts and Entrepreneurship
Somos Esenciales:通过拉丁裔艺术和创业精神实现社区复兴和健康
  • 批准号:
    10781761
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
High Intensity Interval Training: Optimizing Exercise Therapy to Mitigate Cardiovascular Disease Risk Following Breast Cancer Chemotherapy
高强度间歇训练:优化运动疗法以降低乳腺癌化疗后的心血管疾病风险
  • 批准号:
    10667675
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Cardiorenal and Metabolic Diseases Research Center
心肾与代谢疾病研究中心
  • 批准号:
    10630577
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Statistical Methods for Data Integration and Applications to Genome-wide Association Studies
数据集成的统计方法及其在全基因组关联研究中的应用
  • 批准号:
    10889298
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Peripheral Artery Disease: Long-term Survival & Outcomes Study (PEARLS)
外周动脉疾病:长期生存
  • 批准号:
    10734991
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
Understanding cancer and comorbidities among American Indian and Alaska Native people
了解美洲印第安人和阿拉斯加原住民的癌症和合并症
  • 批准号:
    10722119
  • 财政年份:
    2023
  • 资助金额:
    $ 4.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了